Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.43 - $5.9 $4,799 - $65,855
-11,162 Reduced 42.34%
15,200 $9,000
Q2 2022

Aug 15, 2022

BUY
$0.38 - $0.64 $1,778 - $2,995
4,681 Added 21.59%
26,362 $13,000
Q1 2022

May 12, 2022

BUY
$0.55 - $0.98 $5,955 - $10,611
10,828 Added 99.77%
21,681 $15,000
Q4 2021

Feb 14, 2022

SELL
$0.9 - $1.31 $2,677 - $3,897
-2,975 Reduced 21.51%
10,853 $11,000
Q3 2021

Nov 15, 2021

SELL
$1.21 - $1.61 $1,287 - $1,713
-1,064 Reduced 7.14%
13,828 $18,000
Q2 2021

Aug 16, 2021

SELL
$1.6 - $2.02 $45,024 - $56,842
-28,140 Reduced 65.39%
14,892 $24,000
Q1 2021

May 17, 2021

BUY
$1.86 - $2.87 $55,742 - $86,011
29,969 Added 229.42%
43,032 $85,000
Q4 2020

Feb 16, 2021

SELL
$1.65 - $2.43 $295,925 - $435,818
-179,349 Reduced 93.21%
13,063 $27,000
Q3 2020

Nov 16, 2020

BUY
$1.6 - $2.35 $283,958 - $417,063
177,474 Added 1188.07%
192,412 $329,000
Q2 2020

Aug 13, 2020

BUY
$1.33 - $2.76 $15,607 - $32,388
11,735 Added 366.38%
14,938 $35,000
Q1 2020

May 15, 2020

BUY
$0.97 - $2.85 $3,106 - $9,128
3,203 New
3,203 $5,000
Q4 2019

Feb 07, 2020

SELL
$1.69 - $3.8 $40,440 - $90,930
-23,929 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$0.61 - $2.21 $22,509 - $81,549
-36,900 Reduced 60.66%
23,929 $44,000
Q2 2019

Aug 13, 2019

BUY
$0.51 - $0.86 $10,589 - $17,857
20,764 Added 51.83%
60,829 $40,000
Q1 2019

May 14, 2019

BUY
$0.51 - $0.82 $6,666 - $10,719
13,072 Added 48.43%
40,065 $25,000
Q4 2018

Feb 14, 2019

SELL
$0.48 - $1.1 $4,791 - $10,981
-9,983 Reduced 27.0%
26,993 $13,000
Q3 2018

Nov 13, 2018

BUY
$1.06 - $1.69 $24,550 - $39,142
23,161 Added 167.65%
36,976 $41,000
Q2 2018

Aug 15, 2018

BUY
$1.56 - $2.51 $13,603 - $21,887
8,720 Added 171.15%
13,815 $22,000
Q1 2018

May 15, 2018

SELL
$0.91 - $2.24 $14,009 - $34,484
-15,395 Reduced 75.13%
5,095 $11,000
Q4 2017

Feb 09, 2018

BUY
$0.78 - $2.1 $9,228 - $24,847
11,832 Added 136.66%
20,490 $19,000
Q3 2017

Nov 14, 2017

BUY
$1.55 - $1.82 $13,419 - $15,757
8,658
8,658 $15,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $223M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.